ES2082833T3 - Uso de monooleina en el tratamiento de la bolsa periodontal. - Google Patents

Uso de monooleina en el tratamiento de la bolsa periodontal.

Info

Publication number
ES2082833T3
ES2082833T3 ES90312246T ES90312246T ES2082833T3 ES 2082833 T3 ES2082833 T3 ES 2082833T3 ES 90312246 T ES90312246 T ES 90312246T ES 90312246 T ES90312246 T ES 90312246T ES 2082833 T3 ES2082833 T3 ES 2082833T3
Authority
ES
Spain
Prior art keywords
monoolein
treatment
periodontal bag
periodontal
bag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312246T
Other languages
English (en)
Inventor
Nalinkant Chunilal Damani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of ES2082833T3 publication Critical patent/ES2082833T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ESTA INVENCION ESTA RELACIONADA CON COMPOSICIONES Y METODOS PARA TRATAR ENFERMEDADES DE LA CAVIDAD BUCAL EN HUMANOS Y ANIMALES INFERIORES UTILIZANDO UN GEL MONOLEATO DE GLICEROL PARA LIBERAR MEDICAMENTOS EN LA CAVIDAD BUCAL.
ES90312246T 1989-11-17 1990-11-08 Uso de monooleina en el tratamiento de la bolsa periodontal. Expired - Lifetime ES2082833T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/439,064 US5262164A (en) 1989-11-17 1989-11-17 Sustained release compositions for treating periodontal disease

Publications (1)

Publication Number Publication Date
ES2082833T3 true ES2082833T3 (es) 1996-04-01

Family

ID=23743140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312246T Expired - Lifetime ES2082833T3 (es) 1989-11-17 1990-11-08 Uso de monooleina en el tratamiento de la bolsa periodontal.

Country Status (14)

Country Link
US (1) US5262164A (es)
EP (2) EP0671175A3 (es)
JP (1) JPH03209313A (es)
KR (1) KR0156916B1 (es)
AT (1) ATE133858T1 (es)
AU (1) AU648761B2 (es)
CA (1) CA2029050C (es)
DE (1) DE69025270T2 (es)
DK (1) DK0429224T3 (es)
ES (1) ES2082833T3 (es)
FI (1) FI98124C (es)
GR (1) GR3018933T3 (es)
IE (1) IE72515B1 (es)
PT (1) PT95896B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
WO1997022331A1 (en) * 1995-12-20 1997-06-26 Unilever N.V. Desensitising toothpaste
GB9617001D0 (en) 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
CA2286052A1 (en) * 1997-04-17 1998-10-29 Lise Sylvest Nielsen A novel bioadhesive drug delivery system based on liquid crystals
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
AU747252B2 (en) 1997-09-09 2002-05-09 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
WO2000067708A2 (en) * 1999-05-07 2000-11-16 Board Of Regents, The University Of Texas System Oral steroidal hormone compositions and methods of use
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
WO2002011688A1 (en) * 2000-08-07 2002-02-14 Unilever N.V. Oral cosmetic composition comprising petroleum jelly enrobing an active agent
US7008646B2 (en) * 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
GB2381449A (en) * 2001-10-31 2003-05-07 Smithkline Beecham Plc Oral hygiene compositions comprising an electron acceptor
JP2003171301A (ja) * 2001-11-09 2003-06-20 Mahidol Univ 歯周炎治療における補助剤としてのカルメグゲル
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20120134936A1 (en) * 2005-03-18 2012-05-31 Lg Household & Health Care Ltd. Tooth Whitener
EP1863438B1 (en) * 2005-03-18 2018-10-24 LG Household & Health Care Ltd. Tooth whitener
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
US8778386B2 (en) 2005-12-13 2014-07-15 Kimberly-Clark Worldwide, Inc. Anti-microbial substrates with peroxide treatment
WO2010010568A1 (en) * 2008-07-22 2010-01-28 Lupin Limited Oral compositions of clindamycin
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
FI20120287L (fi) * 2011-10-26 2013-04-27 Patolab Oy Hartsihappoja sisältävä vesikoostumus käytettäväksi antimikrobisena hoitoaineena ja lisäaineena
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
EP4100029A4 (en) 2020-02-03 2024-03-06 Curemast, Inc. COMPOSITIONS AND METHODS OF USING THEM FOR THE TREATMENT OF MASTITIS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976251A (en) * 1957-04-19 1961-03-21 Eastman Kodak Co Glycerol fatty acid partial ester gels
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US4098885A (en) * 1977-10-14 1978-07-04 Zoecon Corporation Equine anthelmintic
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4219458A (en) * 1978-10-02 1980-08-26 Monsanto Company Block copolymer hot melt adhesive compositions
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
ATE77559T1 (de) * 1986-11-14 1992-07-15 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
DK254289D0 (da) * 1989-05-25 1989-05-25 Dumex Ltd As Middel til behandling af svampeinfektioner
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5084267A (en) * 1989-11-17 1992-01-28 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
EP0429224B1 (en) 1996-02-07
CA2029050A1 (en) 1991-05-18
AU6667890A (en) 1991-05-23
PT95896A (pt) 1991-09-13
KR910009242A (ko) 1991-06-28
CA2029050C (en) 1997-01-07
FI905682L (fi) 1991-05-18
PT95896B (pt) 1998-01-30
IE72515B1 (en) 1997-04-23
ATE133858T1 (de) 1996-02-15
US5262164A (en) 1993-11-16
AU648761B2 (en) 1994-05-05
IE904149A1 (en) 1991-05-22
EP0429224A1 (en) 1991-05-29
DE69025270D1 (de) 1996-03-21
FI98124C (fi) 1997-04-25
JPH03209313A (ja) 1991-09-12
FI905682A0 (fi) 1990-11-16
DK0429224T3 (da) 1996-06-24
EP0671175A2 (en) 1995-09-13
EP0671175A3 (en) 1996-02-28
FI98124B (fi) 1997-01-15
GR3018933T3 (en) 1996-05-31
DE69025270T2 (de) 1997-01-23
KR0156916B1 (ko) 1998-11-16

Similar Documents

Publication Publication Date Title
ES2082833T3 (es) Uso de monooleina en el tratamiento de la bolsa periodontal.
ES2099977T3 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
ES2067696T3 (es) Composiciones de liberacion sostenida para tratar la enfermedad periodontal.
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
DK20488D0 (da) Farmaceutiske praeparater med forlaenget afgivelse
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ES2061650T3 (es) Composiciones para el tratamiento de la enfermedad periodontal.
MX3783E (es) Procedimiento para la preparacion de composiciones para el tratamiento de enfermedades bucales y dentales
ES2054005T3 (es) Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva.
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
DE69815277D1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
ES2055433T3 (es) Un preparado para el tratamiento de infecciones fungales.
MX9704105A (es) Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis.
IT1275623B1 (it) Uso terapeutico e cosmetico degli allumi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 429224

Country of ref document: ES